Guibin Qiao

Papers

Total Citations

H-Index

About

Guibin Qiao is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment, particularly non-small-cell lung cancer (NSCLC). His major contributions center on comparing the effectiveness and patient-centered outcomes of robotic-assisted thoracoscopic surgery (RATS), video-assisted thoracoscopic surgery (VATS), and traditional open thoracotomy. In his highly cited 2023 meta-analysis (12 citations), Qiao systematically demonstrated that minimally invasive approaches can achieve comparable oncologic efficacy to open surgery for patients with N2 disease, while offering significant benefits in recovery and reduced morbidity. His pioneering 2024 study (7 citations) broke new ground by examining early patient-reported outcomes (PROs) after RATS versus VATS lobectomy, providing crucial evidence that robotic assistance may improve postoperative quality of life and pain management. By integrating rigorous meta-analytic methods with innovative PRO research, Qiao has helped establish evidence-based guidelines for surgical decision-making in NSCLC. His work is particularly impactful for surgeons and oncologists seeking to optimize both survival outcomes and patient experience, cementing his reputation as a key voice in the evolution of thoracic oncology surgery.